Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany

被引：0
|
作者：
Gessner, C. [1 ]
Akyildiz, B. [2 ]
Grickschat, V [2 ]
Borucki, T. [2 ]
Trinkmann, F. [3 ]
机构：
[1] Pneumol Praxis Leipzig, Leipzig, Germany
[2] Chiesi GmbH Hamburg, Hamburg, Germany
[3] Heidelberg Univ, Dept Pneumol & Crit Care Med, Thoraxklin, Heidelberg, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.1187
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1187
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
    Trinkmann, Autoren F.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S36
  • [2] Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Slawinska, R.
    Wendt, A.
    Bogoevska, V
    Gessner, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] Change in lung function after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Wendt, A.
    Licht, B.
    Criee, C.
    PNEUMOLOGIE, 2023, 77 : S36 - S36
  • [4] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Nachtigall, D.
    Bogoevska, V
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S29 - S29
  • [5] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Koczulla, A.
    Akyildiz, B.
    Slawinska, R.
    Martini, M.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S35
  • [6] Improvement of health-related quality of life after 3 months of treatment with extrafine singleinhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Martini, M.
    Meyer-Duderstaedt, T.
    Koczulla, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] TriOptimize X: Improved adherence by extrafine single-inhaler triple therapy in real-world
    Criee, C.
    Trinkmann, F.
    Gueldenring, S.
    Loeper, N.
    Bogoevska, V
    Gessner, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [8] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] Change in treatment adherence after three months of treatment with extrafine formulation single-inhaler triple therapy in patients with asthma: the TriMaximize study
    Trinkmann, Frederik
    Akyildiz, Berktan
    Ulrik, Charlotte Suppli
    Nachtigall, Detlef
    Pohl, Wolfgang
    Bogoevska, Valentina
    Russell, Richard
    Grickschat, Veronika
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
12345